
AXSM Valuation
Axsome Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
AXSM Relative Valuation
AXSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AXSM is overvalued; if below, it's undervalued.
Historical Valuation
Axsome Therapeutics Inc (AXSM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 7.64 is considered Undervalued compared with the five-year average of -18.11. The fair price of Axsome Therapeutics Inc (AXSM) is between 636.20 to 654.17 according to relative valuation methord. Compared to the current price of 104.62 USD , Axsome Therapeutics Inc is Undervalued By 83.56%.
Relative Value
Fair Zone
636.20-654.17
Current Price:104.62
83.56%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
98.39
P/B
Median3y
44.37
Median5y
42.68
-2.35
FCF Yield
Median3y
-3.84
Median5y
-4.63
Competitors Valuation Multiple
The average P/S ratio for AXSM's competitors is 174.58, providing a benchmark for relative valuation. Axsome Therapeutics Inc Corp (AXSM) exhibits a P/S ratio of 7.64, which is -95.62% above the industry average. Given its robust revenue growth of 61.95%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

ASAN
Asana Inc
14.945
USD
+0.03%

ZETA
Zeta Global Holdings Corp
15.765
USD
-0.79%

FTDR
Frontdoor Inc
59.160
USD
+0.80%

POR
Portland General Electric Co
41.430
USD
+4.28%

RDNT
RadNet Inc
56.930
USD
+1.68%

BC
Brunswick Corp
59.525
USD
+0.23%

IPAR
Interparfums Inc
122.660
USD
+0.54%

PECO
Phillips Edison & Co Inc
34.620
USD
-0.40%

SKYW
SkyWest Inc
112.230
USD
+0.95%

SLAB
Silicon Laboratories Inc
134.215
USD
-1.20%
FAQ

Is Axsome Therapeutics Inc (AXSM) currently overvalued or undervalued?
Axsome Therapeutics Inc (AXSM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 7.64 is considered Undervalued compared with the five-year average of -18.11. The fair price of Axsome Therapeutics Inc (AXSM) is between 636.20 to 654.17 according to relative valuation methord. Compared to the current price of 104.62 USD , Axsome Therapeutics Inc is Undervalued By 83.56% .

What is Axsome Therapeutics Inc (AXSM) fair value?

How does AXSM's valuation metrics compare to the industry average?

What is the current P/B ratio for Axsome Therapeutics Inc (AXSM) as of Jul 25 2025?

What is the current FCF Yield for Axsome Therapeutics Inc (AXSM) as of Jul 25 2025?

What is the current Forward P/E ratio for Axsome Therapeutics Inc (AXSM) as of Jul 25 2025?
